Weisheng Xu
Molecular Biology · 2004–2007
A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 2 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 35 citations into it; #10,697 of 17,773 by trust here, #10,695 by citations
Whom Weisheng Xu trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Weisheng Xu overall
Papers from Weisheng Xu's perspective
Ordered by how strongly the researchers Weisheng Xu trusts endorse each paper. Same corpus, a different order for every researcher.
- HDAC6 is a microtubule-associated deacetylase (Nature)
- The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. (Cell)
- Cloning and Functional Characterization of HDAC11, a Novel Member of the Human Histone Deacetylase Family* (Journal of Biological Chemistry)
- Anticancer activities of histone deacetylase inhibitors (Nature reviews. Drug discovery)
- The Sir2 family of protein deacetylases. (Annual Review of Biochemistry)
- Targeting death and decoy receptors of the tumour-necrosis factor superfamily (Nature Reviews. Cancer)
- Acetylation and deacetylation of non-histone proteins. (Gene)
- Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. (Molecules and Cells)
- Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. (Journal of Molecular Biology)
- Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. (Structure)
Their papers
- Histone deacetylase inhibitors: molecular mechanisms of action (2007) — 1,515 citations
- Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1. (2004) — 600 citations